Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
GDUFA III Talks Completed; Fees will Fund Inspection, Complex Generic Improvements
Sep 02 2021
•
By
Derrick Gingery
GDUFA III was the last of three FDA human drug and biologic user fee renewal agreements to be completed. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from Pathways & Standards